The year of the Pandemic, Drug-Biotech life line rally, will extend into next year.
Daily rate of new cases world wide hit an all time record 2 days ago, 330,000 new cases in one day.
124 Million annual rate and rising exponentially.
I will adding ACHFF to my Biotech drug retirement stock list.
Daily rate of new cases world wide hit an all time record 2 days ago, 330,000 new cases in one day.
124 Million annual rate and rising exponentially.
I will adding ACHFF to my Biotech drug retirement stock list.
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
Recent ACHFF News
- Arch Biopartners Closes Non-Brokered Private Placement • GlobeNewswire Inc. • 04/02/2026 09:45:00 AM
- Arch Biopartners Arranges Non-Brokered Private Placement • GlobeNewswire Inc. • 03/30/2026 10:03:00 AM
- Arch Biopartners and the Fraser Health Authority enter into a Clinical Trial Agreement for the Phase II Cardiac Surgery-Associated AKI Trial • GlobeNewswire Inc. • 03/24/2026 01:13:43 PM
- Arch Biopartners Announces St. Michael’s Hospital Commences Patient Dosing in the Phase II CS-AKI Trial of LSALT Peptide • GlobeNewswire Inc. • 03/20/2026 11:05:00 AM
- Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease • GlobeNewswire Inc. • 02/09/2026 12:28:52 PM
- Arch Biopartners Announces Appointment of Dr. Patrick Vink as Chairman of the Board • GlobeNewswire Inc. • 01/16/2026 01:15:00 PM
- Arch Biopartners Announces Ethics Approval for St. Michael’s Hospital to Participate in the Phase II Cardiac Surgery-Associated AKI Trial for LSALT Peptide • GlobeNewswire Inc. • 12/16/2025 12:40:00 PM
- Arch Biopartners Closes Non-Brokered Private Placement • GlobeNewswire Inc. • 11/19/2025 09:27:50 PM
- Arch Biopartners Arranges Non-Brokered Private Placement • GlobeNewswire Inc. • 11/10/2025 01:10:00 PM
- Arch Biopartners Expands Phase II Cardiac Surgery-Associated AKI Trial to Include Royal Columbian Hospital in British Columbia • GlobeNewswire Inc. • 11/05/2025 01:30:00 PM
- Arch Strengthens its Position as a Leading Kidney Therapeutics Company with the Acquisition of a Breakthrough Platform to Develop New Drugs Targeting Chronic Kidney Disease (CKD) • GlobeNewswire Inc. • 09/17/2025 11:15:00 AM
